PubMed Health⌕ Search

PubMed · 16146679

Systematic comparison of different functionality columns for a classical pharmaceutical problem.

Abstract

The performance of five reversed-phase columns which included a standard C18 phase, a polar embedded phase (amide group), a polyethyleneglycol phase, a cyano phase, and a perfluorinated phase, all coming from the same manufacturer, have been studied. They were systematically compared with a test mixture containing basic, neutral and acidic compounds of very different polarities, as well as different functional groups (acetaminophen, phenylephrine hydrochloride or phenylpropanolamine hydrochloride, chlorpheniramine maleate, 4-aminophenol, 4-chloracetanilide and 4-nitrophenol) at three pH levels (2.5, 4.6 and 7.0) and three proportions of buffer/acetonitrile (80:20, 50:50 and 20:80, v/v). The results obtained have permitted our group to develop unique applications with these columns, as these compounds are not only a test mixture, due to their chemical characteristics, but they are also usually contained in pharmaceutical formulations for the relief of common cold symptoms and have been selected as a real-life case study. Moreover, after observing the reversed-phase and normal-phase-like characteristics for certain analytes on the perfluorinated phase, a systematic study was developed in this column to understand the chromatographic behaviour of these compounds at three pH (2.5, 4.6 and 7.0) and seven different organic proportions from 20 to 80% acetonitrile. The predominant electrostatic interactions observed on the perfluorinated phase could explain its special behaviour and the high retention at higher percentages of organic solvent, especially for amine compounds, which makes this column very advantageous in working with LC/MS. Different applications with volatile buffers, such as TFA at pH 2.5 and ammonium acetate at pH 4.6 and 7.0, were also considered. Some results have been related to parameters frequently employed for column description.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Marín, C Barbas. 2005-09-16. Systematic comparison of different functionality columns for a classical pharmaceutical problem.. https://doi.org/10.1016/j.jpba.2005.07.028

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of 1% diclofenac gel in the treatment of wrist extensor tenosynovitis in long distance kayakers.

Anecdotally many athletes use non-steroidal anti-inflammatory gels during competition to allow continued participation. To determine if this clinical practice is useful a randomised placebo-controlled study was conducted at the 5-day 2004 Red Cross Murray River Marathon. Forty-two kayakers presented with wrist extensor tenosynovitis while competing in the single and double kayak events. All subjects received standard treatment of ice, stretches and massage for wrist tenosynovitis before being randomised into a placebo or 1% diclofenac gel group. Evaluation was done by using a visual analogue scale (0-10) for pain and by clinical grading (0-3). The main outcome measurements were reduction in pain and clinical grading, the requirement for a rescue medication (paracetamol or diclofenac tablets) and effect on performance times. Both groups had similar pain scores and clinical grading on the first and fifth days of pain. On the second to fourth days of pain there was clearly no benefit and possibly a detrimental effect on pain with diclofenac gel relative to placebo. However, diclofenac tablets were possibly beneficial for pain relative to paracetamol tablets. The effects of pain and the various treatments on performance time were either trivial (<0.5%) or small, but none was particularly clear. We conclude that standard treatment appears to be sufficient for the management of wrist extensor tenosynovitis during competition.

Acetaminophen↗

Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity.

Neutrophils are recruited into the liver after acetaminophen (AAP) overdose but the pathophysiological relevance of this acute inflammatory response remains unclear. To address this question, we compared the time course of liver injury, hepatic neutrophil accumulation and inflammatory gene mRNA expression for up to 24 h after treatment with 300 mg/kg AAP in C3Heb/FeJ and C57BL/6 mice. Although there was no relevant difference in liver injury (assessed by the increase of plasma alanine aminotransferase activities and the areas of necrosis), the number of neutrophils and the expression of several pro-inflammatory genes (e.g., tumor necrosis factor-alpha, interleukin-1beta and macrophage inflammatory protein-2) was higher in C3Heb/FeJ than in C57BL/6 mice. In contrast, the expression of the anti-inflammatory genes interleukin-10 and heme oxygenase-1 was higher in C57BL/6 mice. Despite substantial hepatic neutrophil accumulation, none of the liver sections from both strains stained positive for hypochlorite-modified proteins, a specific marker for a neutrophil-induced oxidant stress. In addition, treatment with the NADPH oxidase inhibitors diphenyleneiodonium chloride or apocynin or the anti-neutrophil antibody Gr-1 did not protect against AAP hepatotoxicity. Furthermore, although intercellular adhesion molecule-1 (ICAM-1) was previously shown to be important for neutrophil extravasation and tissue injury in several models, ICAM-1-deficient mice were not protected against AAP-mediated liver injury. Together, these data do not support the hypothesis that neutrophils aggravate liver injury induced by AAP overdose.

Acetaminophen↗

Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.

OBJECTIVE: To assess the use of n-of-1 trials for short-term choice of drugs for osteoarthritis, with particular reference to comparing the efficacy of sustained-release [SR] paracetamol with celecoxib in individual patients. METHODS: Evaluation of community-based patients undergoing n-of-1 trials which consisted of double-blind, crossover comparisons of celecoxib 200 or 400 mg/day with sustained-release paracetamol 1330 mg three times a day in three pairs of 2 week treatment periods per drug with random order of the drugs within pairs. Outcomes evaluated were pain and stiffness in sites nominated by the patient, functional limitation scores, preferred medication, side effects and changes in drug use after an n-of-1 trial. Participants were 59 patients with osteoarthritis in multiple sites (hip 6, knee 24, hand 6, shoulder/neck 8, back 14, foot 5), with pain for >or=1 month severe enough to warrant consideration of long-term use of celecoxib but for whom there was doubt about its efficacy. Forty-one n-of-1 trials were completed. RESULTS: Although on average, celecoxib showed better scores than SR paracetamol [0.2 (0.1) for pain, 0.3 (0.1) for stiffness and 0.3 (0.1) for functional limitation], 33 of the 41 individual patients (80%) failed to identify the differences between SR paracetamol and celecoxib in terms of overall symptom relief. Of the eight patients who were able to identify the differences, seven had better relief with celecoxib and one with SR paracetamol. In 25 out of 41 [61%] patients, subsequent management was consistent with their trial results. CONCLUSIONS: N-of-1 trials may provide a rational and effective method to best choose drugs for individuals with osteoarthritis. SR paracetamol is more useful than celecoxib for most patients of whom management is uncertain.

Acetaminophen↗